Skip to content
Pharma Observatory a Scientist.com platform

Organization (Industry)

Xtant Medical Holdings, Inc.

ClinicalTrials.gov lists Xtant Medical Holdings, Inc. as lead sponsor of 18 trials, counting the companies grouped under it.

US Industry Manufacturer CIK 0001453593
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Companies grouped under this page Companies grouped under this page 1 Disease areas Disease areas 2 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 2 Sponsor delivery record Sponsor delivery record 1 US granted patents US granted patents 1 SEC-reported annual financials SEC-reported annual financials 11 Financing and grant events Financing and grant events 57 FDA inspection record FDA inspection record 1 Companies grouped under this page Companies grouped under this page 1 Disease areas Disease areas 2 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 2 Sponsor delivery record Sponsor delivery record 1 US granted patents US granted patents 1 SEC-reported annual financials SEC-reported annual financials 11 Financing and grant events Financing and grant events 57 FDA inspection record FDA inspection record 1

Rows recorded per section (log scale)

5 more sections with rows · 11 sections measured, none recorded

This page covers Xtant Medical Holdings, Inc. and 1 company grouped under it: 18 lead-sponsored trials (2 its own, 16 in the grouped companies) and 3 legal-entity registrations (2 its own, 1 in the grouped companies).

Get the Xtant Medical Holdings, Inc. report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Companies grouped under this page (1)

Companies grouped under this page
Company Lead trials Legal entities
RTI Surgical (United States) 16 1

Disease areas (2)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Intervertebral Disc Degeneration 1
Spinal Stenosis 1

Trials by start year as sponsor or collaborator (2)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials by start year as sponsor or collaborator
Year Trials started
2020 1
2019 1

No forecast is made for this organization: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

Sponsor delivery record (1)

Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.

Sponsor delivery record
Enrollment Timeline
0 of 1 hit target (n=1) 0 of 1 on time (n=1)

US granted patents (1)

Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.

US granted patents
US patents granted Granted in the last 5 years Most recent grant
22 12 2025-09-09

SEC-reported annual financials (11)

Shown in this order: newest fiscal year first; SEC EDGAR XBRL companyfacts, USD as reported.

SEC-reported annual financials
Fiscal year Revenue (USD) Net income (USD) R&D (USD)
2025 133,927,000 4,973,000 2,102,000
2024 117,267,000 -16,449,000 2,385,000
2023 91,303,000 660,000 1,336,000
2022 57,969,000 -8,485,000 915,000
2021 55,263,000 -4,849,000 870,000
2020 53,337,000 -7,023,000 657,000
2019 64,682,000 -8,221,000 932,000
2018 72,203,000 -70,099,000 1,702,000
2017 82,612,000 -52,411,000 2,441,000
2016 90,002,736 -19,493,552 3,410,600

Showing 10 of 11 fiscal years.

Start your 14-day trial Email me all 11 fiscal years as a PDF

Financing and grant events (57)

Shown in this order: most recent first.

Financing and grant events
Date Round type Amount (USD) Source
2026-04-10 Other financing not disclosed Sec extracted
2026-02-27 Debt financing not disclosed Sec extracted
2026-02-27 Other financing not disclosed Sec extracted
2025-12-01 Other financing not disclosed Sec extracted
2025-12-01 Other financing 8,200,000 Sec extracted

Showing 5 of 57 events.

Start your 14-day trial Email me the first 50 events as a PDF

FDA inspection record (1)

FDA inspection record
Latest classification Inspections
NAI 15

FDA recalls (16)

Shown in this order: most recent first.

FDA recalls
Product Classification Initiated
nanOss 3D Advanced Bone Graft Substitute nanOss 3D Plus Advanced Bone Graft Substitute 90-300-251008: nanOss 3D Advanced Bone Graft Substitute, 25x100x8mm, 20cc 90-300-25508: nanOss 3D Advanced Bone Graft Substitute, 25x50x8mm, 10cc 90-300-251004: nanOss 3D Advanced Bone Graft Substitute, 25x100x4mm, 10cc 90-400-25508: nanOss 3D Plus Advanced Bone Graft Substitute, 25x50x8mm, 10cc Class II 2026-03-09
XTANT MEDICAL Xpress Pedicle Screw System Dual Lead 6.5 x 50 mm, Part Number X073-6555-DL. Class II 2026-02-18
Irix-A Integrated Lumbar Fusion System, Model Number X080-423011-08PC (Spacer Assy, 42 X 30 X 8¿, 11mm, PC (STERILE)) and Model Number X080-382819-08PC (Spacer ASSY, 38 X 28 X 8¿, 19mm, PC, (STERILE)) Class II 2025-01-03
Cortera Spinal Fixation System Screw, Poly, Solid, 6.5mm x 45mm, REF: 150100-65045 Class II 2024-08-21
Cortera Spinal Fixation System, REF: 150100-85050. Spinal fixation screws labeled as 8.5 mm diameter, 50 mm length. Class II 2023-11-28

Showing 5 of 16 recalls.

Start your 14-day trial Email me all 16 recalls as a PDF

Manufacturing and distribution sites (1)

Manufacturing and distribution sites
Facility Location Regulators Member organization
Xtant Medical Holdings, Inc. Belgrade, US FDA

Climate targets, as filed (1)

Climate targets, as filed
Reporting year Net-zero target
2025 not disclosed

Workforce and board diversity, as filed (1)

Workforce and board diversity, as filed
Reporting year Workforce % women Board % women
2025 not disclosed not disclosed

Latest dated events (112)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-04-10 Financing Funding rounds and grants (NIH RePORTER + SEC EDGAR)
2026-03-09 FDA recall FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment)
2026-02-27 Financing Funding rounds and grants (NIH RePORTER + SEC EDGAR)
2026-02-27 Debt facility Funding rounds and grants (NIH RePORTER + SEC EDGAR)
2026-02-18 FDA recall FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment)

Showing 5 of 112 events.

Start your 14-day trial Email me the first 50 events as a PDF

Not on this page

Checked, with nothing recorded for this organization: related companies not grouped here, active development programs, approved assets, journals published in, fda warning letters, fda untitled letters, fda import refusals, organization relationships, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.